Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Caldesmon 1 (CALD1) Peptide

CALD1 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN938461
$398.38
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 16 to 22 Business Days

Quick Overview for Caldesmon 1 (CALD1) Peptide (ABIN938461)

Target

Caldesmon (CALD1) (Caldesmon 1 (CALD1))

Origin

Mammalian

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Peptide Type

    Synthetic

    Sequence

    FSSPTAAGTP NKETAGLKVG VSSRINEWLT KTPDGNKSPA PKPSDLRPGD

    Characteristics

    A synthetic peptide for use as a blocking control in assays to test for specificity of CALD1 antibody,
    Alternative Names: Caldesmon 1 control peptide, Caldesmon 1 antibody Blocking Peptide, Anti-Caldesmon 1 Blocking Peptide, CALD1 Blocking Peptide, CDM Blocking Peptide, H-CAD Blocking Peptide, L-CAD Blocking Peptide, MGC21352 Blocking Peptide, NAG22 Blocking Peptide
  • Application Notes

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C long term.
  • Target

    Caldesmon (CALD1) (Caldesmon 1 (CALD1))

    Background

    CALD1 is a calmodulin- and actin-binding protein that plays an essential role in the regulation of smooth muscle and nonmuscle contraction. The conserved domain of this protein possesses the binding activities to Ca(2+)-calmodulin, actin, tropomyosin, myosin, and phospholipids. This protein is a potent inhibitor of the actin-tropomyosin activated myosin MgATPase, and serves as a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction.

    Molecular Weight

    63 kDa
You are here:
Chat with us!